BD 2672034 - PowerLoc PAK Safety Infusion Set with Y-Injection Site, 20G x 0.75", 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

BD 2672034 - PowerLoc PAK Safety Infusion Set with Y-Injection Site, 20G x 0.75", 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

The BD 2672034 PowerLoc PAK Safety Infusion Set is a sterile, single-use port-access solution designed for accessing compatible surgically implanted vascular ports. The set features a 20-gauge non-coring needle with a 0.75-inch length and includes a Y-injection site for secondary access to the infusion pathway.

The PowerLoc system provides a fluid pathway for administering compatible medications and solutions, withdrawing blood specimens, flushing implanted ports, and delivering contrast media through appropriately rated power-injectable ports. The 20-gauge configuration provides a balance between needle diameter and flow capability for a broad range of infusion and diagnostic imaging applications.

The 0.75-inch needle length is intended for implanted ports positioned relatively close to the skin surface. Proper needle-length selection helps ensure secure access to the port septum while supporting stable positioning and effective dressing application.

An integrated safety mechanism is designed to help reduce accidental needlestick exposure during port deaccessing. As the needle is removed from the implanted port and enters the base, a protective shield covers the needle point and the needle locks into position. Tactile, audible, and visual confirmation help verify safety activation before handling and disposal.

The PowerLoc design features a compact, low-profile footprint that supports dressing application, site visibility, and patient care. The PAK presentation provides an organized, all-in-one solution intended to simplify the multi-step sterile port-access preparation process. BD 2672034 is supplied five sets per case.

Key Benefits

• 20-gauge non-coring needle supports access to compatible implanted vascular ports.
• 0.75-inch needle length is suitable for appropriately positioned superficial ports.
• Power-injectable design supports compatible contrast-enhanced imaging procedures.
• Supports power-injection flow rates up to 5 mL per second when the complete system is properly rated.
• Y-injection site provides secondary access for compatible medication or fluid administration.
• Non-coring needle design helps minimize unnecessary damage to the implanted port septum.
• Integrated safety mechanism covers and locks the needle point after removal.
• Tactile, audible, and visual confirmation support verification of safety activation.
• Low-profile design supports dressing placement and access-site management.
• Small footprint helps maintain visibility around the implanted port access site.
• Winged design supports controlled insertion and stabilization.
• Downward-angled tubing helps support dressing integrity and tubing positioning.
• Compatible with appropriate dual-lumen implanted ports.
• PAK format helps organize components used during sterile port-access preparation.
• Five-per-case packaging supports controlled inventory management.

Compatibility and Applications

The BD 2672034 PowerLoc PAK Safety Infusion Set is intended for use with compatible surgically implanted vascular access ports designed to accept non-coring port-access needles.

Potential clinical applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, blood product administration, long-term infusion therapy, blood specimen collection, implanted port flushing, and contrast-media delivery during compatible diagnostic imaging procedures.

The 20-gauge needle may be selected when the prescribed therapy requires moderate-to-high flow capability while maintaining a smaller diameter than a 19-gauge access needle. Selection should consider medication viscosity, required flow rate, implanted port specifications, infusion-pump requirements, and clinical judgment.

The 0.75-inch length is generally appropriate for ports positioned relatively close to the skin surface. A needle that is too short may not completely access the port septum, while an unnecessarily long needle may affect stability, securement, and dressing placement.

The integrated Y-injection site provides a secondary access point within the tubing. It may support compatible intermittent medication administration, flushing, or connection of another approved fluid pathway when permitted by institutional policy and the intended procedure.

When used for power injection, the implanted port, access needle, tubing, connectors, Y-site, extension components, and every other device within the fluid pathway must be specifically rated for power injection. The lowest-rated component determines the maximum allowable pressure and flow rate.

Compatibility should be confirmed with the exact implanted port model, septum design, port depth, prescribed therapy, infusion pump, power injector, connector system, dressing materials, and institutional vascular-access procedures.

Usage Guidelines

The BD 2672034 should be used only by healthcare professionals trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and the implanted port manufacturer's directions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status.
• Assess the location and depth of the implanted port before selecting the 0.75-inch needle.
• Verify that the 20-gauge configuration is appropriate for the intended infusion or imaging procedure.
• Confirm that the Y-injection site configuration is suitable for the planned clinical workflow.
• Inspect the sterile package for punctures, moisture, damage, contamination, or compromised integrity.
• Prepare the port-access site according to institutional antisepsis and sterile-access procedures.
• Prime the infusion tubing and intended fluid pathways completely with an approved solution.
• Remove air from the system before accessing the implanted port.
• Stabilize the port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle carefully until appropriate contact with the base of the port reservoir is achieved.
• Verify correct placement according to facility policy, including aspiration for blood return when clinically appropriate.
• Flush the implanted port according to current manufacturer instructions and institutional protocol.
• Position and secure the tubing to reduce pulling, twisting, pressure, and dressing disruption.
• Apply an approved sterile dressing and maintain appropriate site visualization.
• Disinfect the Y-injection site before every access according to facility protocol.
• Maintain aseptic technique whenever connecting to or manipulating the Y-site.
• Monitor the site for pain, swelling, redness, leakage, displacement, or other complications.
• Confirm power-injection eligibility before connecting the system to a power injector.
• Do not exceed 5 mL per second or the lower operating limit of any connected component.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Stabilize the port while withdrawing the needle and activating the safety mechanism.
• Confirm that the needle point is covered and locked before handling.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the port-access system if resistance occurs during flushing, expected blood return cannot be obtained, the patient experiences unusual discomfort, or swelling, leakage, or another abnormality develops at the access site.

Certifications and Safety Standards

The BD 2672034 PowerLoc PAK Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, diagnostic imaging, infection-prevention, and occupational safety programs.

The device should be incorporated into facility procedures covering implanted port assessment, sterile preparation, skin antisepsis, port access, infusion administration, connection management, dressing care, power injection, deaccessing, and sharps disposal.

The integrated safety mechanism is designed to cover and lock the needle point after removal from the implanted port. Tactile feel, an audible click, and visual confirmation support verification of safety activation before transportation and disposal.

The safety feature does not replace appropriate clinician training, personal protective equipment, safe sharps handling, exposure-control procedures, or immediate disposal in an approved sharps container.

The non-coring needle is intended to access the septum of a compatible implanted vascular port while helping minimize unnecessary septum damage when used correctly. Needle gauge and length must be selected according to patient anatomy, port depth, prescribed therapy, and manufacturer instructions.

Healthcare organizations should review current manufacturer documentation for applicable FDA clearance, UDI information, sterilization method, shelf life, material composition, natural rubber latex status, DEHP information, pressure limits, flow-rate specifications, and other technical or regulatory requirements.

Comparison with Competitors

Compared with conventional implanted port needles without integrated safety features, the BD PowerLoc system includes a mechanism that covers and locks the needle point during deaccessing. This can help reduce accidental needlestick exposure between needle removal and final sharps disposal.

Compared with infusion sets that do not include a Y-injection site, BD 2672034 provides a secondary access point within the tubing. This may support compatible intermittent medication administration or additional fluid connections without disconnecting the primary pathway.

Compared with non-power-injectable port-access devices, the PowerLoc platform supports compatible power-injection procedures when used with an approved power-injectable implanted port and within all specified operating limits.

Compared with a 19-gauge PowerLoc configuration, the 20-gauge needle provides a smaller diameter while retaining power-injection capability up to 5 mL per second under appropriate conditions. Compared with a 22-gauge model, the 20-gauge configuration generally supports higher flow requirements.

Compared with 1-inch and 1.5-inch access needles, the 0.75-inch configuration provides a lower profile for implanted ports positioned closer to the skin surface. Correct needle-length selection supports proper septum access and dressing stability.

Compared with loose individual port-access supplies, the PAK presentation organizes essential components into one procedural package. This can help simplify preparation and promote consistency across clinical teams.

Alternative safety infusion sets may vary in gauge, needle length, safety mechanism, power-injection capability, Y-site design, tubing configuration, included components, and package quantity. BD 2672034 combines a 20-gauge, 0.75-inch non-coring needle with a Y-injection site, integrated safety technology, and organized PAK presentation.

Typical User Profile and Application Scenarios

The BD 2672034 PowerLoc PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified clinical personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other healthcare facilities where implanted vascular ports are routinely accessed.

The product may be selected for patients whose implanted port can be accessed appropriately with a 0.75-inch needle and whose prescribed treatment or diagnostic procedure is compatible with a 20-gauge device.

Typical application scenarios include chemotherapy administration, antibiotic infusion, hydration, parenteral nutrition, blood specimen collection, routine port maintenance, blood product administration, and power injection of contrast media during compatible imaging procedures.

The Y-injection site is particularly useful in workflows requiring secondary access for compatible intermittent medication administration, flushing, or connection of another approved fluid pathway.

Best Practices for Use and Maintenance

The BD 2672034 is a sterile, single-use medical device and does not require maintenance as reusable equipment. Best practices focus on correct storage, product selection, sterile preparation, port-access technique, Y-site management, site monitoring, safety activation, and disposal.

• Store unopened sets under the environmental conditions specified by the manufacturer.
• Protect packages from moisture, excessive heat, freezing, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 2672034 catalog number before opening the package.
• Confirm the 20-gauge size, 0.75-inch length, and presence of the Y-injection site.
• Assess the patient's tissue depth and implanted port position before selecting the needle length.
• Confirm that the required therapy and flow rate are appropriate for a 20-gauge device.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime all intended fluid pathways completely before accessing the implanted port.
• Stabilize the port during both needle insertion and removal.
• Position the tubing to avoid unnecessary pulling or pressure at the access site.
• Scrub and disinfect the Y-injection site before each access according to institutional policy.
• Keep unused access points capped and protected from contamination.
• Monitor the port site and tubing connections throughout therapy.
• Verify the power-injectable status of the complete system before a powered procedure.
• Never exceed the lowest pressure or flow-rate limit of any connected component.
• Do not bend, cut, modify, repair, or otherwise alter the infusion set.
• Do not reuse, clean, resterilize, or reprocess the single-use device.
• Confirm complete safety activation immediately after needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 2672034 PowerLoc PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 20-gauge size, 0.75-inch needle length, Y-injection site configuration, sterile package integrity, expiration date, and compatibility with the implanted vascular port. Do not use a device that is expired, damaged, contaminated, or supplied in compromised packaging.

The set should not be used for power injection unless the implanted port and every connected component are specifically rated for power injection. The permitted pressure, flow rate, contrast-media viscosity, and other operating conditions must be confirmed before beginning the procedure.

Compatible 20-gauge PowerLoc configurations support power-injection flow rates up to 5 mL per second when used under manufacturer-specified conditions. The lowest-rated component within the complete system determines the maximum allowable operating limit.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may cause infiltration, extravasation, tissue injury, leakage, implanted port damage, interrupted therapy, or other complications.

The Y-injection site should be accessed only with compatible devices using appropriate disinfection and aseptic technique. Improper manipulation or inadequate disinfection may increase the risk of contamination, connection failure, or bloodstream infection.

The integrated safety mechanism should be activated according to current manufacturer instructions. The used device remains a contaminated sharp after deaccessing and must be discarded immediately in an approved sharps container.

The product is supplied five sets per case. Purchasing personnel should confirm current availability, shipping eligibility, storage requirements, order quantity, and return conditions before purchasing.

How to Order

Select the BD 2672034 - PowerLoc PAK Safety Infusion Set with Y-Injection Site, 20G x 0.75" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.